INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies

  The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.

• Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site

  Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

• Empowering Patients With Self-Administration Drug Delivery Devices

  Discover how these devices offer solutions to the challenges of precise dosing, patient compliance, retention, and safety, uplifting the overall trial experience and providing real world insights.

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  4/7/2026

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• Manufacturing Made More Robust And Customer-Centric

  12/11/2025

  Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

• Outsourcing To ISO 17025 Accredited Suppliers

  1/28/2025

  Discover the advantages of outsourcing equipment calibration to ISO 17025 accredited suppliers, including cost efficiency and regulatory assurance, in our detailed analysis. Read more to transform your calibration processes.

• Moving Batch Release Into The Fast Lane

  1/21/2026

  Complex supply chains and fragmented systems slow batch release, delaying patient access and revenue goals. Learn how automation and centralized data improve compliance and accelerate delivery.

• How To Select The Right Fill-Finish CDMO For Phase I–II

  3/16/2026

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.